Myeloperoxidase metabolizes thiocyanate in a reaction driven by nitric oxide

Biochemistry

Volumn 45, Issue 4, 2006, Pages 1255-1262

  Galijasevic, Semira ^a   Saed, Ghassan M ^a   Hazen, Stanley L ^c   Abu Soud, Husam M ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATALYSIS; COMPUTER SIMULATION; ELECTRON TRANSITIONS; ENZYMES; NITROGEN OXIDES; PEROXIDES; PHYSIOLOGICAL MODELS; SPECTROSCOPIC ANALYSIS; SUBSTRATES;

CATALYTIC INTERMEDIATE COMPOUND; MYELOPEROXIDASE (MPO); PHYSIOLOGICAL RELEVANCE; THIOCYANATE;

ENZYME KINETICS;

MYELOPEROXIDASE; NITRIC OXIDE; THIOCYANATE;

ARTICLE; CATALYSIS; ENZYME ACTIVITY; ENZYME KINETICS; ENZYME MECHANISM; ENZYME SUBSTRATE; KINETICS; OXIDATION; PEROXIDATION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN METABOLISM; PROTEIN PROTEIN INTERACTION; SPECTROSCOPY; STEADY STATE;

CATALYSIS; COMPUTER SIMULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYDROGEN PEROXIDE; KINETICS; LEUKOCYTES; LIPID METABOLISM; NITRIC OXIDE; OXIDATION-REDUCTION; PEROXIDASE; SUBSTRATE SPECIFICITY; THIOCYANATES; TIME FACTORS;

EID: 31544475400     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi051438k     Document Type: Article

References (49)

1. Klebanoff, S. J., and Clark, R. A. (1987) The Neutrophil: Functions and Clinical Disorders, pp 1-810, Elsevier Science Publisher B. V., Amsterdam.
2. Klebanoff, S. J. (2005) Myeloperoxidase: friend and foe, J. Leukocyte Biol. 77, 598-625.
3. Hazen, S. L., and Heinecke, J. W. (1997) 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low-density lipoprotein isolated from human atherosclerotic intima, J. Clin. Invest. 99, 2075-2081.
4. Podrez, E. A., Schmitt, D., Hoff, H. F., and Hazen, S. L. (1999) Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro, J. Clin. Invest. 103, 1547-1560.
5. Thukkani, A. K., McHowat, J., Hsu, F., Brennan, M. L., Hazen, S. L., and Ford, D. A. (2003) Identification of alpha-chloro fatty aldehydes and unsaturated lysophosphatidylcholine molecular species in human atherosclerotic lesions, Circulation 108, 3128-3133.
6. Nicholls, S. J., and Hazen, S. L., (2005) Myeloperoxidase and cardiovascular disease, Arteriosder. Thromb. Vasc. Biol. 25, 1102-1111.
7. Brennan, M. L., Penn, M. S., Van Lente, F., Nambi, V., Shishehbor, M. H., Aviles, R. J., Goormastic, M., Pepoy, M. L., McErlean, E. S., Topol, E. J., Nissen, S. E., and Hazen, S. L. (2003) Prognostic value of myeloperoxidase in patients with chest pain, N. Engl. J. Med. 349, 1595-1604.
8. Weiss, S. J., Klein, R., Slivka, A., and Wei, M. (1982) Chlorination of taurine by human neutrophils. Evidence for hypochlorous acid generation, J. Clin. Invest. 70, 589-607.
9. Harrison, J. E., and Schultz, J. (1976) Studies on the chlorinating activity of myeloperoxidase, J. Biol. Chem. 251, 1371-1374.
10. Kettle, A. J., van Dalen, C. J., and Winterbourn, C. C. (1997) Peroxynitrite and myeloperoxidase leave the same footprint in protein nitration, Redox Rep. 3, 257-258.
11. Klebanoff, S. J. (1999) Myeloperoxidase, Proc. Assoc. Am. Physicians 111, 383-389.
12. Podrez, E. A., Abu-Soud, H. M., and Hazen, S. L. (2000) Myeloperoxidase-generated oxidants and atherosclerosis, Free Radical Biol. Med. 28, 1717-1725.
13. Nauseef, W. M. (1998) Insights into myeloperoxidase biosynthesis from its inherited deficiency, J. Mol. Med. 76, 661-618.
14. Petrides, P. E., and Nauseef, W. M. (2000) The Peroxidase Multi-Gene Family of Enzymes: Biochemical Basis and Clinical Applications (Petrides, P. E., and Nauseef, W. M., Eds.), Springer-Verlag, Berlin, Germany.
15. Abu-Soud, H. M., and Hazen, S. L. (2000) Nitric oxide modulates the catalytic activity of myeloperoxidase, J. Biol. Chem. 275, 5425-5430.
16. Abu-Soud, H. M., and Hazen, S. L. (2000) Nitric oxide is a physiological substrate for mammalian peroxidases, J. Biol. Chem. 275, 37524-37532.
17. Abu-Soud, H. M., Khassawneh, M. Y., Sohn, J. T., Murray, P., Haxhiu, M. A., and Hazen, S. L. (2001) Peroxidases inhibit nitric oxide (NO) dependent bronchodilation: development of a model describing NO-peroxidase interactions, Biochemistry 40, 11866-11875.
18. Galijasevic, S., Saed, G. M., Diamond, M. P., and Abu-Soud, H. M. (2003) Myeloperoxidase up-regulates the catalytic activity of inducible nitric oxide synthase by preventing nitric oxide feedback inhibition, Proc. Natl. Acad. Sci. U.S.A. 100, 14766-14771.
19. van Dalen, C. J., and Kettle, A. J. (2001) Substrates and products of eosinophil peroxidase, Biochem. J. 358, 233-239.
20. Winterbourn, C. C., and Kettle, A. J. (2004) Reactions of superoxide with myeloperoxidase and its products, Jpn. J. Infect. Dis. 57, S31-S33.
21. Nielsen, F. H. (1986) in Trace Elements In Human and Animal Nutrition (Mertz, W., Ed.) Vol. 2, pp 426-430, Academic Press, Orlando, FL.
22. van Dalen, C. J., Whitehouse, M. W., Winterbourn, C. C., Kettle, A. J. (1997) Thiocyanate and chloride as competing substrates for myeloperoxidase, Biochem. J. 327, 487-492.
23. Teitz, N. W. (1994) Teitz Textbook of Clinical Chemistry (Burtis, C. A., and Ashwood, E. R., Eds.) 2nd ed., p 2216, W. B. Saunders Co., Philadelphia, PA.
24. Thomas, E. L., Bozeman, P. M., Jefferson, M. M., and King, C. C. (1995) Oxidation of bromide by the human leukocyte enzymes myeloperoxidase and eosinophil peroxidase. Formation of bromamines, J. Biol. Chem. 270, 2906-2913.
25. van der Vliet, A., Eiserich, J. P., Halliwell, B., and Cross, C. E. (1997) Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite. A potential additional mechanism of nitric oxide-dependent toxicity, J. Biol. Chem. 272, 7617-7625.
26. Tahboub, Y. R., Galijasevic, S., Diamond, M. P., and Abu-Soud, H. M. (2005) Thiocyanate modulates the catalytic activity of mammalian peroxidases, J. Biol. Chem. 280, 26129-26136.
27. Furtmuller, P. G., Burner, U., Regelsberger, G., and Obinger, C. (2000) Spectral and kinetic studies on the formation of eosinophil peroxidase compound I and its reaction with halides and thiocyanate, Biochemistry 39, 15578-15584.
28. Azen, E. A. (1978) Salivary peroxidase activity and thiocyanate concentration in human subjects with genetic variants of salivary peroxidase, Arch. Oral Biol. 23, 801-805.
29. Ferguson, D. B. (1987) Current diagnostic uses of saliva, J. Dent. Res. 66, 420-424.
30. Stevens, K. R., and Munoz, L. R. (2004) Cigarette smoking: Evidence to guide measurement, Res. Nurs. Health 27, 281-292.
31. Scherer, G., and Richter, E. (1997) Biomonitoring exposure to environmental tobacco smoke (ETS): a critical reappraisal, Hum. Exp. Toxicol. 16, 449-459.
32. Bottoms, S. F., Kuhnert, B. R., Kuhnert, P. M., and Reese, A. L. (1982) Maternal passive smoking and fetal serum thiocyanate levels, Am. J. Obstet. Gynecol. 144, 787-791.
33. McMahon, M. J., Brown, H. L., and Dean, R. A. (1997) Umbilical cord thiocyanate and thyroid function in intrauterine growth-restricted infants of the smoking gravida, J. Perinatol. 17, 370-374.
34. Thayer J. R., and Huffaker, R. C. (1980) Determination of nitrate and nitrite by high-pressure liquid chromatography: comparison with other methods for nitrate determination, Anal. Biochem. 102, 110-119.
35. Rakita, R. M., Michel, B. R., and Rosen, H. (1990) Differential inactivation of Escherichia coli membrane dehydrogenases by a myeloperoxidase-mediated antimicrobial system, Biochemistry 29, 1075-1080.
36. Wever, R., Plat, H., and Hamers, M. N. (1981) Human eosinophil peroxidase: a novel isolation procedure, spectral properties and chlorinating activity. Kinetics of oxidation of tyrosine and dityrosine by myeloperoxidase compounds I and II. Implications for lipoprotein peroxidation studies, FEBS Lett. 123, 327-331.
37. Agner, K. (1963) Studies on myeloperoxidase activity, Acta Chem. Scand. 17, S332-S338.
38. Marquez, L. A., and Dunford, H. B. (1995) Kinetics of oxidation of tyrosine and dityrosine by myeloperoxidase compounds I and II. Implications for lipoprotein peroxidation studies, J. Biol. Chem. 270, 30434-30440.
39. Arnhold, J., Furtmuller, P, G., and Obinger, C. (2003) Redox properties of myeloperoxidase, Redox Rep. 8, 179-186.
40. Dunford, H. B., and Hsuanyu, Y. (1999) Kinetics of oxidation of serotonin by myeloperoxidase compounds I and II, Biochem. Cell Biol. 77, 449-457.
41. Stelmaszynska, T., and Zgliczynski, J. M. (1974) Myeloperoxidase of human neutrophilic granulocytes as chlorinating enzyme, Eur. J. Biochem. 45, 305-312.
42. Furtmuller, P. G., Burner, U., and Obinger, C. (1998) Reaction of myeloperoxidase compound I with chloride, bromide, iodide, and thiocyanate, Biochemistry 37, 17923-17930.
43. Ghibaudi, E., Laurenti, E., Pacchiardo, C., Suriano, G., Moguilevsky, N., Pia Ferrari, R. (2003) Organic and inorganic substrates as probes for comparing native bovine lactoperoxidase and recombinant human myeloperoxidase, J. Inorg. Biochem. 94, 146-154.
44. 2-Cl-antimicrobial system at acid and neutral pH, Proc. Exp. Biol. Med. 154, 418-422.
45. Bakkenist, A. R. J., de Boer, J. E., Plat, H., and Wever, R. (1980) The halide complexes of myeloperoxidase and the mechanism of the halogenation reactions, Biochim. Biophys. Acta 613, 337-348.
46. Andrews, P. C., and Krinsky, N. I. (1982) A kinetic analysis of the interaction of human myeloperoxidase with hydrogen peroxide, chloride ions, and protons, J. Biol. Chem. 257, 13240-13245.
47. Zeng, J., and Fenna, R. E. (1992) X-ray crystal structure of canine myeloperoxidase at 3 Å resolution, J. Mol. Biol. 226, 185-207.
48. Fiedler, T. J., Davey, C. A., and Fenna, R. E. (2000) X-ray crystal structure and characterization of halide-binding sites of human myeloperoxidase at 1.8 Å resolution, J. Biol. Chem. 275, 11964-11971.
49. Davey, C. A., and Fenna, R. E. (1996) 2.3 Å resolution X-ray crystal structure of the bisubstrate analogue inhibitor salicylhydroxamic acid bound to human myeloperoxidase: a model for a prereaction complex with hydrogen peroxide, Biochemistry 35, 10967-10973.